Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Marchioli

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Haematologica|June 14, 2005
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levelsPhilipp L Goerttler, Edith März, Peter L Johansson, et al.
European Heart Journal|June 15, 2007
Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione studyBenedetta D Chiodini, Maria Grazia Franzosi, Simona Barlera, et al.
Lancet (London, England)|September 2, 2008
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLuigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, et al.
Lancet (London, England)|September 2, 2008
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLuigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, et al.
Journal of the American College of Cardiology|July 19, 2014
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosisSigrun Halvorsen, Felicita Andreotti, Jurriën M ten Berg, et al.
International Journal of Cardiology|July 9, 2011
Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trialGiacomo Levantesi, RosaMaria Marfisi, Dariush Mozaffarian, et al.
American Heart Journal|March 1, 2006
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoringAlejandro Macchia, Giacomo Levantesi, Giovanna Borrelli, et al.
European Journal of Heart Failure|October 19, 2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trialStefano Ghio, Laura Scelsi, Roberto Latini, et al.
The New England Journal of Medicine|May 10, 2013
n-3 fatty acids in patients with multiple cardiovascular risk factors, Maria Carla Roncaglioni, Massimo Tombesi, et al.
International Journal of Cardiology|January 21, 2012
Uric acid: a cardiovascular risk factor in patients with recent myocardial infarctionGiacomo Levantesi, Rosa Maria Marfisi, Maria Grazia Franzosi, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Haematologica|June 14, 2005
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levelsPhilipp L Goerttler, Edith März, Peter L Johansson, et al.
European Heart Journal|June 15, 2007
Apolipoprotein E polymorphisms influence effect of pravastatin on survival after myocardial infarction in a Mediterranean population: the GISSI-Prevenzione studyBenedetta D Chiodini, Maria Grazia Franzosi, Simona Barlera, et al.
Lancet (London, England)|September 2, 2008
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLuigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, et al.
Lancet (London, England)|September 2, 2008
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLuigi Tavazzi, Aldo P Maggioni, Roberto Marchioli, et al.
Journal of the American College of Cardiology|July 19, 2014
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosisSigrun Halvorsen, Felicita Andreotti, Jurriën M ten Berg, et al.
International Journal of Cardiology|July 9, 2011
Wine consumption and risk of cardiovascular events after myocardial infarction: results from the GISSI-Prevenzione trialGiacomo Levantesi, RosaMaria Marfisi, Dariush Mozaffarian, et al.
American Heart Journal|March 1, 2006
A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoringAlejandro Macchia, Giacomo Levantesi, Giovanna Borrelli, et al.
European Journal of Heart Failure|October 19, 2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trialStefano Ghio, Laura Scelsi, Roberto Latini, et al.
The New England Journal of Medicine|May 10, 2013
n-3 fatty acids in patients with multiple cardiovascular risk factors, Maria Carla Roncaglioni, Massimo Tombesi, et al.
International Journal of Cardiology|January 21, 2012
Uric acid: a cardiovascular risk factor in patients with recent myocardial infarctionGiacomo Levantesi, Rosa Maria Marfisi, Maria Grazia Franzosi, et al.
Pageof 11